Human CDK1 activation kit by CRISPRa

CAT#: GA100700

CDK1 CRISPRa kit - CRISPR gene activation of human cyclin dependent kinase 1



  See Other Versions

CNY 12255.00


货期*
4周

规格
    • 1 kit

Product images

推荐一起购买 (3)
Phospho-CDK1-Y15 Rabbit polyclonal Antibody
    • 100 ul

CNY 2900.00

热销推荐


CDK1 (Myc-DDK-tagged)-Human cyclin-dependent kinase 1 (CDK1), transcript variant 1
    • 10 ug

CNY 2400.00
CNY 4465.00


CDK1 Rabbit monoclonal Antibody
    • 100 ul

CNY 1999.00
CNY 3280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol CDK1
Locus ID 983
Kit Components

GA100700G1, CDK1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100700G2, CDK1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100700G3, CDK1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_001130829, NM_001170406, NM_001170407, NM_001786, NM_033379, NM_001320918
Synonyms CDC28A; CDK1; DKFZp686L20222; MGC111195
Summary The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G1/S and G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...